Drawtex® is a hydroconductive wound dressing with LevaFiber Technology. LevaFiber is a combination of two types of absorbent differentiated structures that creates the ability to draw exudate away from the wound surface. Drawtex tracheostomy and tube dressing is designed specifically for application around a tracheostomy tube after tracheostomy surgery. The keyhole aperture in the dressing allows it to fit neatly around a tracheostomy tube or other drain or stoma to collect fluid and exudates from the tracheostomy site and ultimately prevent peristomal maceration.
LevaFiber™ Technology provides three different types of action.
Wound bed preparation is the management of a wound in order to accelerate endogenous healing or to facilitate the effectiveness of other therapeutic measures. Recent data have been published showing how wound treatment with Drawtex assists with the complex challenges of wound bed preparation.
Using an advanced pattern-recognition software algorithm to analyze digital wound images, researchers calculated wound measurements and analyzed tissue composition of the wound bed. They found:
• Drawtex actively draws fluid away from the wound up to 150 cc/hour, retaining its integrity when moist.
• Drawtex helps to remove debris from the wound by drawing out fibrin and slough, while leaving healthy granulation tissue in
Another study concluded that the advantages of exudate removal by Drawtex were numerous. Not only was the fluid removed, but nutrients in the exudate that facilitate biofilm production were also drawn off.
A study that evaluated Drawtex in an infected burn model demonstrated that Drawtex can draw methicillin-resistant Staphylococcus aureus (MRSA) from either an inoculated broth or an experimental burn wound eschar.
Similar results were reported in patients with chronic wounds, where tissue biopsy bacterial counts decreased from 106 to 102 CFUs per gram of tissue, while at the same time the bacterial counts in the Drawtex dressings increased up to 104 CFUs.
Chronic wounds have excessive inflammation, increased pro-inflammatory cytokines, increased proteases such as MMPs, and decreased growth factors. Removing or decreasing the harmful MMPs is an important aspect of wound bed preparation.
• One study reported that Drawtex could draw MMP-9 and transport it for a distance up to 7 cm from the wound.
• Another similar study showed that both MMP-9 and MMP-1 were drawn out of chronic wounds with Drawtex wound dressings, with a concomitant rise in MMPs in the Drawtex dressings.
Drawtex can be easily cut and shaped to fit each type of wound
Drawtex Tracheostomy & Tube Dressing has 3 mechanisms of action to actively manage sputum, enteric or urinary fluid, and other secretions detrimental to skin integrity.
Drawtex Rope takes the Drawtex technology even deeper, allowing you to reach deeper undermined or tunneled areas in your wounds without fear of losing the dressing due to saturation. It is comfortable to any environment where fluid needs to be removed, managed, or contained.
Drawtex is indicated for wounds with moderate to high levels of exudate, including:
Drawtex may be cut to conform to wound shape. Any side of Drawtex can be used against the wound bed.
For dry or less exudative wounds, apply a nonadherent (perforated) dressing, such as UrgoTul Contact Layer or UrgoTul Ag Contact Layer, before applying Drawtex. For best results, ensure nonadherent dressing has direct contact with wound bed.
For moderately to highly exudative wounds, apply Drawtex directly to wound bed. For heavy exudate, apply additional layers as necessary.
Cover with a secondary dressing or bandage of choice.
Change Drawtex every 1 to 3 days, as necessary. Once exudate is under control, dressing may be changed less frequently. If Drawtex is adherent, irrigate with saline for easy removal.
THIN PROFILE, COMFORTABLE DESIGN, IDEAL FOR WRAPPING DIFFICULT AREAS
Drawtex is available in a variety of sizes. Ordering information can be found in the table below.